SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001768824-19-000004
Filing Date
2019-03-01
Accepted
2019-03-01 13:23:22
Documents
1
Group Members
MARK FELDBERGSHIRA CAPITAL LLCTRADELINK SECURITIES LLCTRIPLETAIL CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 OVID 13D FILING efc19-259.htm SC 13D 235874
  Complete submission text file 0001768824-19-000004.txt   237421
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90350 | Film No.: 19648047
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 NORTH BISCAYNE BLVD MIAMI FL 33132
Business Address 100 NORTH BISCAYNE BLVD MIAMI FL 33132 3122642196
TLS Advisors LLC (Filed by) CIK: 0001768824 (see all company filings)

IRS No.: 205570195
Type: SC 13D